{"id":"W3139304883","doi":"10.1177/1758835921998586","title":"Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Myovant Sciences","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Adverse effect; Testosterone (patch); Management of prostate cancer; Internal medicine; Oncology; Gonadotropin-releasing hormone; Androgen; Androgen suppression; Cancer; Luteinizing hormone; Endocrinology; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001103759,0.0002713923,0.0003332537,0.0002856159,0.0001706715,0.0002416803,0.0002690843,0.000249452,0.001849406],"category_scores_gemma":[0.0001002924,0.00007316087,0.0003688174,0.0001774436,0.000132045,0.0002339283,0.0002835885,0.0008265521,0.0005165181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001711487,"about_ca_system_score_gemma":0.0003108801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004047164,"about_ca_topic_score_gemma":0.00160113,"domain_scores_codex":[0.9999442,0.00001179578,0.000004950018,0.00001120351,0.00001790323,0.000009958276],"domain_scores_gemma":[0.9999688,0.000003596663,0.000009574111,0.000001467598,0.000003329714,0.00001332778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003122661,0.001128917,0.001717962,0.002455081,0.0001899462,0.001029024,0.000122143,0.0006504675,0.05136162,0.001129459,0.01535219,0.9217406],"study_design_scores_gemma":[0.01397866,0.04588014,0.05040254,0.001102215,0.0008204578,0.03748771,0.0002025853,0.004180839,0.04702637,0.00222129,0.7964679,0.0002292162],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4355199,0.5031688,0.01431057,0.006569081,0.001575334,0.001130296,0.001680065,0.001670014,0.03437592],"genre_scores_gemma":[0.803578,0.1569286,0.01523104,0.005610624,0.0009644875,0.00050662,0.002290007,0.0001002719,0.01479047],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001849406,"threshold_uncertainty_score":0.006186903,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0585975078822475,"score_gpt":0.4545254438389683,"score_spread":0.3959279359567208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}